Photo of Ron Estes
R United States House · District 4 · Kansas On the 2026 ballot

Rep. Ron Estes

Compare
Total votes
2,818
all sessions
Attendance
97%
77 missed
Higher than 76% of chamber peers
With party
94%
of cast votes
Near the chamber average
Bipartisan score
3%
crosses aisle rarely
Near the chamber average
Sponsored
523
bills & resolutions
Lower than 88% of chamber peers
Committees
5
assignments
523 bills and resolutions

Sponsored bills

Total
523
Primary
49
Co-sponsor
474
This page
523
matching current filters
Co-sponsor HR 581
In committee · Delaware House · Co-sponsor
Ensuring Accurate and Complete Abortion Data Reporting Act of 2021

Ensuring Accurate and Complete Abortion Data Reporting Act of 2021 This bill requires states, as a condition of federal payment under Medicaid for family planning services, to report certain abortion data to the Centers for Disease Control and Prevention (CDC). (Currently, reporting is voluntary.) The CDC must develop standardized questions for states with respect to specified variables (e.g., maternal demographics and methods of abortion).

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 552
In committee · Delaware House · Co-sponsor
Second Chance at Life Act of 2021

Second Chance at Life Act of 2021 This bill requires abortion providers to disclose information about the possibility of reversing a medication abortion. This is a procedure that uses a medication regimen to terminate a pregnancy, typically with a two-drug protocol.  Providers must inform patients that it may be possible to reverse the effects of a medication abortion after taking the first drug. They must also let patients know that more information and assistance is available on the Department of Health and Human Services (HHS) website. At least 24 hours before the procedure, the provider must share this information with the patient in person or by telephone. The provider must also include the information in written discharge instructions after the first drug is dispensed. The bill sets out an exception to these notification requirements when an abortion is necessary to resolve a physical injury or condition that threatens the life of the woman. The provider must document the circumstances giving rise to the exception in the patient's medical file. Furthermore, providers must post signs with this information in their offices or facilities, and HHS must maintain information about reversing medication abortions on its website.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 541
In committee · Delaware House · Co-sponsor
Defund Planned Parenthood Act of 2021

Defund Planned Parenthood Act of 2021 This bill restricts federal funding for Planned Parenthood Federation of America Inc. or any of its affiliates or clinics for one year. Specifically, it prohibits funding those entities unless they certify that the affiliates and clinics will not perform, and will not provide funds to entities that perform, abortions during that year. If the certification requirement is not met, the Department of Health and Human Services and the Department of Agriculture must recoup any federal assistance received by those entities. However, the bill's funding restriction does not apply to abortions performed in cases of rape or incest or when necessary to resolve a physical condition that endangers a woman's life. The bill also provides additional funding for community health centers for the one-year period. These funds are subject to the same abortion-related restrictions and exceptions.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 554
In committee · Delaware House · Co-sponsor
SAVE Moms and Babies Act of 2021

Support And Value Expectant Moms and Babies Act of 2021 or the SAVE Moms and Babies Act of 2021 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner to also act as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 471
In committee · Delaware House · Co-sponsor
PAUSE Act of 2021

Protecting Americans from Unnecessary Spread upon Entry from COVID-19 Act of 2021 or the PAUSE Act of 2021 This bill maintains immigration restrictions put in place under public health emergency authorities to prevent the introduction of COVID-19 (i.e., coronavirus disease 2019) from foreign countries. Specifically, the bill prohibits the Department of Health and Human Services from rescinding or reducing the stringency of the restrictions. It also prohibits the Department of Homeland Security from stopping or reducing enforcement of the restrictions. These prohibitions remain in effect until (1) federal and state COVID-19 emergency orders are lifted, and (2) the risk of introducing COVID-19 in or from Canada and Mexico is minimal.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 243
In committee · Delaware House · Co-sponsor
Title X Abortion Provider Prohibition Act

Title X Abortion Provider Prohibition Act This bill prohibits the Department of Health and Human Services (HHS) from awarding family planning grants to entities that perform abortions or provide funding to other entities that perform abortions. To receive a grant, an entity must certify it will refrain from those activities during the grant period. The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness. It also exempts hospitals unless they provide funds to non-hospital entities that provide abortions. HHS must report annually on this prohibition.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 28
In committee · Delaware House · Co-sponsor
Protecting Life in Crisis Act

Protecting Life in Crisis Act This bill specifies that federal funds allocated for COVID-19 (i.e., coronavirus disease 2019) response efforts may not, in general, be used for abortions. Current law generally prohibits the use of federal funds for abortions through language included in appropriations bills, such as the Hyde Amendment. The bill also restricts the use of federal tax credits or other federal funding for health insurance coverage if the coverage includes abortions.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HRES 71
In committee Jan 28, 2021 1 co-sponsor
Co-sponsor HR 497
In committee · Delaware House · Co-sponsor
To prohibit the use of funds to seek membership in the World Health Organization or to provide assessed or voluntary contributions to the World Health Organization.

This bill prohibits the use of federal funds to seek U.S. membership in the World Health Organization (WHO), or to make contributions to the WHO, until the President makes certain certifications to Congress. Specifically, the prohibition shall apply until the President certifies that the WHO (1) has adopted reforms to ensure that humanitarian assistance is not politicized; (2) is not under the control of the Chinese Communist Party (CCP) and is not involved in a cover-up of the CCP's response to the COVID-19 (i.e., coronavirus disease 2019) pandemic; (3) has granted observer status to Taiwan; (4) does not divert humanitarian or medical supplies to Iran, North Korea, or Syria; and (5) has put in place mechanisms to increase transparency and eliminate waste, fraud, and abuse.

In committee Jan 28, 2021 1 co-sponsor
Showing 511 to 520 of 523 bills